Location: Menlo Park, CA
CIK: 0001819257 · Show all filings
Period: Q4 2025 (← Previous) (Next →)
Filing Date: Feb 12, 2026
Total Value: $467M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ROIV | ROIVANT SCIENCES LTD | 8,166,047 | $177M | 37.9% | $7.21 | +173.5% | SHS | G76279101 |
| INSM | INSMED INC | 267,000 | $46.47M | 9.9% | $73.51 | +148.2% | COM PAR $.01 | 457669307 |
| MIRM | MIRUM PHARMACEUTICALS INC | 298,682 | $23.59M | 5.1% | $62.11 | +15.6% | COM | 604749101 |
| ARGX | ARGENX SE | 26,000 | $21.86M | 4.7% | $668.23 | — | SPONSORED ADR | 04016X101 |
| ONC | BEONE MEDICINES LTD | 69,312 | $21.06M | 4.5% | $303.81 | — | SPONSORED ADS | 07725L102 |
| ABVX | ABIVAX SA | 130,000 | $17.53M | 3.8% | $84.90 | — | SPONSORED ADS | 00370M103 |
| PHVS | PHARVARIS N V | 542,696 | $15.06M | 3.2% | $21.02 | +14.6% | COM | N69605108 |
| EYPT | EYEPOINT INC | 780,000 | $14.25M | 3.1% | $8.71 | +62.6% | COM NEW | 30233G209 |
| TERN | TERNS PHARMACEUTICALS INC | 320,000 | $12.93M | 2.8% | $23.11 | 0.0% | COM | 880881107 |
| CELC | CELCUITY INC | 120,000 | $11.97M | 2.6% | $47.06 | +74.7% | COM | 15102K100 |
| COGT | COGENT BIOSCIENCES INC | 317,372 | $11.27M | 2.4% | $28.11 | 0.0% | COM | 19240Q201 |
| KYMR | KYMERA THERAPEUTICS INC | 139,000 | $10.82M | 2.3% | $46.83 | +44.2% | COM | 501575104 |
| LQDA | LIQUIDIA CORPORATION | 227,000 | $7.829M | 1.7% | $13.90 | +104.8% | COM NEW | 53635D202 |
| DBVT | DBV TECHNOLOGIES S A | 359,050 | $6.883M | 1.5% | $19.17 | — | SPONSORED ADS | 23306J309 |
| ALLO | ALLOGENE THERAPEUTICS INC | 4,963,756 | $6.8M | 1.5% | $1.76 | -24.9% | COM | 019770106 |
| DNTH | DIANTHUS THERAPEUTICS INC | 150,000 | $6.181M | 1.3% | $27.76 | +39.7% | COM | 252828108 |
| XENE | XENON PHARMACEUTICALS INC | 136,500 | $6.118M | 1.3% | $42.00 | 0.0% | COM | 98420N105 |
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | 210,000 | $6.098M | 1.3% | $25.60 | 0.0% | COM | 03969K108 |
| OCUL | OCULAR THERAPEUTIX INC | 490,000 | $5.949M | 1.3% | $8.36 | +45.3% | COM | 67576A100 |
| IRON | DISC MEDICINE INC | 74,000 | $5.876M | 1.3% | $57.12 | +47.9% | COM | 254604101 |
| AVTX | AVALO THERAPEUTICS INC | 311,966 | $5.665M | 1.2% | $14.22 | +18.7% | COM NEW | 05338F306 |
| SYRE | SPYRE THERAPEUTICS INC | 150,000 | $4.914M | 1.1% | $26.13 | 0.0% | COM NEW | 00773J202 |
| ELVN | ENLIVEN THERAPEUTICS INC | 308,141 | $4.745M | 1.0% | $23.51 | -15.3% | COM | 29337E102 |
| ASMB | ASSEMBLY BIOSCIENCES INC | 127,000 | $4.319M | 0.9% | $21.94 | +46.8% | COM NEW | 045396207 |
| AMLX | AMYLYX PHARMACEUTICALS INC | 350,000 | $4.228M | 0.9% | $9.81 | +38.4% | COM | 03237H101 |
| RCUS | ARCUS BIOSCIENCES INC | 170,000 | $4.051M | 0.9% | $20.40 | 0.0% | COM | 03969F109 |
| CATX | PERSPECTIVE THERAPEUTICS INC | 1,132,815 | $3.115M | 0.7% | $3.10 | -7.9% | COM NEW | 46489V302 |
| HROW | HARROW INC | 7,031 | $345K | 0.1% | $41.98 | 0.0% | COM | 415858109 |